140 related articles for article (PubMed ID: 7533005)
1. Arabinogalactan for hepatic drug delivery.
Groman EV; Enriquez PM; Jung C; Josephson L
Bioconjug Chem; 1994; 5(6):547-56. PubMed ID: 7533005
[TBL] [Abstract][Full Text] [Related]
2. Larch arabinogalactan for hepatic drug delivery: isolation and characterization of a 9 kDa arabinogalactan fragment.
Prescott JH; Enriquez P; Jung C; Menz E; Groman EV
Carbohydr Res; 1995 Nov; 278(1):113-28. PubMed ID: 8536264
[TBL] [Abstract][Full Text] [Related]
3. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
Leveille-Webster CR; Rogers J; Arias IM
Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
Pathak PO; Nagarsenker MS; Barhate CR; Padhye SG; Dhawan VV; Bhattacharyya D; Viswanathan CL; Steiniger F; Fahr A
Carbohydr Res; 2015 May; 408():33-43. PubMed ID: 25841057
[TBL] [Abstract][Full Text] [Related]
5. Spin labelled arabinogalactan as MRI contrast agent.
Gallez B; Lacour V; Demeure R; Debuyst R; Dejehet F; De Keyser JL; Dumont P
Magn Reson Imaging; 1994; 12(1):61-9. PubMed ID: 8295509
[TBL] [Abstract][Full Text] [Related]
6. Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor.
Fiume L; Di Stefano G; Busi C; Mattioli A; Bonino F; Torrani-Cerenzia M; Verme G; Rapicetta M; Bertini M; Gervasi GB
J Viral Hepat; 1997; 4(6):363-70. PubMed ID: 9430355
[TBL] [Abstract][Full Text] [Related]
7. Asialoglycoprotein receptor is uninvolved in clearing intact glycoproteins from rat blood.
Clarenburg R
Am J Physiol; 1983 Mar; 244(3):G247-53. PubMed ID: 6187222
[TBL] [Abstract][Full Text] [Related]
8. Targeted protection of hepatocytes from galactosamine toxicity in vivo.
Keegan-Rogers V; Wu GY
Cancer Chemother Pharmacol; 1990; 26(2):93-6. PubMed ID: 1693313
[TBL] [Abstract][Full Text] [Related]
9. Hepatic fibronectin matrix turnover in rats: involvement of the asialoglycoprotein receptor.
Rotundo RF; Vincent PA; McKeown-Longo PJ; Blumenstock FA; Saba TM
Am J Physiol; 1999 Dec; 277(6):G1189-99. PubMed ID: 10600816
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and biodisposition of fluorescein-labeled arabinogalactan in rats.
Kaneo Y; Ueno T; Tanaka T; Iwase H; Yamaguchi Y; Uemura T
Int J Pharm; 2000 May; 201(1):59-69. PubMed ID: 10867265
[TBL] [Abstract][Full Text] [Related]
11. Killing of cultured hepatocytes by conjugates of asialofetuin and EGF linked to the A chains of ricin or diphtheria toxin.
Simpson DL; Cawley DB; Herschman HR
Cell; 1982 Jun; 29(2):469-73. PubMed ID: 6180832
[TBL] [Abstract][Full Text] [Related]
12. A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy.
Besra GS; Khoo KH; McNeil MR; Dell A; Morris HR; Brennan PJ
Biochemistry; 1995 Apr; 34(13):4257-66. PubMed ID: 7703239
[TBL] [Abstract][Full Text] [Related]
13. Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody.
Marshall D; Pedley RB; Melton RG; Boden JA; Boden R; Begent RH
Br J Cancer; 1995 Jan; 71(1):18-24. PubMed ID: 7529526
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of asialoglycoproteins in cultured rat hepatocytes: evidence for receptor mediated uptake and degradation which is not feed-back regulated.
Drevon CA; Tolleshaug H; Carlander B; Berg T
Int J Biochem; 1983; 15(6):827-33. PubMed ID: 6190689
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate-mediated clearance of secretory IgA from the circulation.
Tomana M; Phillips JO; Kulhavy R; Mestecky J
Mol Immunol; 1985 Aug; 22(8):887-92. PubMed ID: 2413348
[TBL] [Abstract][Full Text] [Related]
16. Uptake of lactosylated low-density lipoprotein by galactose-specific receptors in rat liver.
Bijsterbosch MK; Van Berkel TJ
Biochem J; 1990 Aug; 270(1):233-9. PubMed ID: 1697748
[TBL] [Abstract][Full Text] [Related]
17. Monensin inhibits receptor-mediated endocytosis of asialoglycoproteins in rat hepatocytes.
Berg T; Blomhoff R; Naess L; Tolleshaug H; Drevon CA
Exp Cell Res; 1983 Oct; 148(2):319-30. PubMed ID: 6195005
[TBL] [Abstract][Full Text] [Related]
18. Conjugation of adenine arabinoside 5'-monophosphate to arabinogalactan: synthesis, characterization, and antiviral activity.
Enriquez PM; Jung C; Josephson L; Tennant BC
Bioconjug Chem; 1995; 6(2):195-202. PubMed ID: 7541249
[TBL] [Abstract][Full Text] [Related]
19. Isolated rat hepatocytes bind lactoferrins by the RHL-1 subunit of the asialoglycoprotein receptor in a galactose-independent manner.
Bennatt DJ; Ling YY; McAbee DD
Biochemistry; 1997 Jul; 36(27):8367-76. PubMed ID: 9204884
[TBL] [Abstract][Full Text] [Related]
20. Targeting of mitomycin C to the liver by the use of asialofetuin as a carrier.
Kaneo Y; Tanaka T; Iguchi S
Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):999-1003. PubMed ID: 1716529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
